Mega Lifesciences PCL (BKK:MEGA)
34.00
0.00 (0.00%)
At close: Dec 4, 2025
Mega Lifesciences PCL Ratios and Metrics
Market cap in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 3, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 29,644 | 28,990 | 35,093 | 40,760 | 44,029 | 31,169 | Upgrade
|
| Market Cap Growth | -9.33% | -17.39% | -13.90% | -7.43% | 41.26% | 37.50% | Upgrade
|
| Enterprise Value | 26,488 | 26,452 | 32,883 | 39,242 | 42,440 | 30,965 | Upgrade
|
| Last Close Price | 34.00 | 31.56 | 36.72 | 41.08 | 42.80 | 29.57 | Upgrade
|
| PE Ratio | 15.01 | 14.41 | 17.61 | 18.18 | 22.62 | 22.38 | Upgrade
|
| Forward PE | 13.27 | 11.29 | 14.52 | 17.76 | 22.85 | 22.25 | Upgrade
|
| PS Ratio | 2.09 | 1.88 | 2.23 | 2.59 | 3.11 | 2.47 | Upgrade
|
| PB Ratio | 3.06 | 2.94 | 3.77 | 4.64 | 5.49 | 4.47 | Upgrade
|
| P/TBV Ratio | 3.53 | 3.39 | 4.40 | 5.47 | 6.62 | 5.52 | Upgrade
|
| P/FCF Ratio | 14.61 | 13.46 | 21.25 | 24.09 | 17.10 | 22.34 | Upgrade
|
| P/OCF Ratio | 11.79 | 12.07 | 18.22 | 20.41 | 16.15 | 19.13 | Upgrade
|
| PEG Ratio | 44.23 | 30.40 | 2.85 | 3.23 | 2.55 | 1.88 | Upgrade
|
| EV/Sales Ratio | 1.87 | 1.72 | 2.09 | 2.50 | 3.00 | 2.46 | Upgrade
|
| EV/EBITDA Ratio | 8.10 | 7.32 | 10.45 | 13.45 | 17.84 | 16.22 | Upgrade
|
| EV/EBIT Ratio | 8.69 | 7.76 | 11.19 | 14.42 | 19.48 | 17.98 | Upgrade
|
| EV/FCF Ratio | 13.05 | 12.28 | 19.91 | 23.19 | 16.48 | 22.20 | Upgrade
|
| Debt / Equity Ratio | 0.06 | 0.05 | 0.03 | 0.05 | 0.04 | 0.09 | Upgrade
|
| Debt / EBITDA Ratio | 0.19 | 0.13 | 0.08 | 0.14 | 0.15 | 0.33 | Upgrade
|
| Debt / FCF Ratio | 0.30 | 0.23 | 0.15 | 0.25 | 0.14 | 0.46 | Upgrade
|
| Asset Turnover | 1.01 | 1.09 | 1.09 | 1.13 | 1.14 | 1.14 | Upgrade
|
| Inventory Turnover | 2.17 | 2.37 | 2.29 | 2.18 | 2.25 | 2.40 | Upgrade
|
| Quick Ratio | 1.58 | 1.79 | 1.40 | 1.10 | 1.08 | 0.90 | Upgrade
|
| Current Ratio | 2.30 | 2.61 | 2.26 | 1.91 | 1.92 | 1.79 | Upgrade
|
| Return on Equity (ROE) | 20.87% | 20.99% | 22.04% | 26.66% | 25.87% | 21.11% | Upgrade
|
| Return on Assets (ROA) | 13.53% | 15.05% | 12.77% | 12.19% | 10.97% | 9.75% | Upgrade
|
| Return on Capital (ROIC) | 19.14% | 21.40% | 19.59% | 19.35% | 17.01% | 14.65% | Upgrade
|
| Return on Capital Employed (ROCE) | 30.20% | 33.10% | 30.30% | 29.90% | 25.90% | 23.50% | Upgrade
|
| Earnings Yield | 6.66% | 6.94% | 5.68% | 5.50% | 4.42% | 4.47% | Upgrade
|
| FCF Yield | 6.85% | 7.43% | 4.71% | 4.15% | 5.85% | 4.48% | Upgrade
|
| Dividend Yield | 4.71% | 5.07% | 4.36% | 3.90% | 3.23% | 3.04% | Upgrade
|
| Payout Ratio | 70.63% | 69.30% | 72.23% | 62.71% | 47.41% | 48.12% | Upgrade
|
| Buyback Yield / Dilution | -0.12% | - | - | - | - | -0.12% | Upgrade
|
| Total Shareholder Return | 4.58% | 5.07% | 4.36% | 3.90% | 3.23% | 2.93% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.